{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:17:47Z","timestamp":1771269467455,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370930"],"award-info":[{"award-number":["31370930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Commission","award":["15XD1524900"],"award-info":[{"award-number":["15XD1524900"]}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association CAS","doi-asserted-by":"publisher","award":["2016249"],"award-info":[{"award-number":["2016249"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012692","name":"K.C.Wong Education Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012692","id-type":"DOI","asserted-by":"crossref"}]},{"name":"TOTAL Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.antiviral.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T20:58:44Z","timestamp":1519073924000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection"],"prefix":"10.1016","volume":"152","author":[{"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.02.016_bib1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1586\/14787210.2015.1058156","article-title":"Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide","volume":"13","author":"Bian","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2018.02.016_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2010.02.002","article-title":"Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland","volume":"48","author":"Blomqvist","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib3","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib4","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcv.2017.05.011","article-title":"Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015","volume":"93","author":"Chen","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib6","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.016_bib7","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.12659\/MSM.900380","article-title":"Virus-like particles produced in Pichia Pastoris induce protective immune responses against coxsackievirus A16 in mice","volume":"22","author":"Feng","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.antiviral.2018.02.016_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2011.12.011","article-title":"Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case","volume":"53","author":"Fuschino","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib9","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1128\/JCM.01231-13","article-title":"Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China","volume":"51","author":"He","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71","volume":"186","author":"Ku","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2018.02.016_bib11","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.016_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.antiviral.2017.06.008","article-title":"A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation","volume":"144","author":"Li","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.016_bib14","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2014.08.064","article-title":"Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"Liu","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.016_bib16","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib17","doi-asserted-by":"crossref","first-page":"e52073","DOI":"10.1371\/journal.pone.0052073","article-title":"Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.02.016_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.02.016_bib19","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1111\/j.1469-0691.2012.03789.x","article-title":"Outbreak of hand, foot and mouth disease\/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study","volume":"18","author":"Mirand","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2018.02.016_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3949\/ccjm.81a.13132","article-title":"Hand, foot, and mouth disease: identifying and managing an acute viral syndrome","volume":"81","author":"Repass","year":"2014","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.antiviral.2018.02.016_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2018.02.016_bib23","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2016.08.033","article-title":"Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2018.02.016_bib25","doi-asserted-by":"crossref","first-page":"e1076","DOI":"10.1016\/j.ijid.2010.07.006","article-title":"The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains","volume":"14","author":"Wu","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.016_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008-12: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.02.016_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jmv.24151","article-title":"Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10","volume":"87","author":"Yang","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2017.6.1.4","article-title":"Enterovirus 71 infection and vaccines","volume":"6","author":"Yi","year":"2017","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.antiviral.2018.02.016_bib29","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.vaccine.2015.03.034","article-title":"High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.02.016_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.02.011","article-title":"Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice","volume":"129","author":"Zhang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.016_bib31","article-title":"Protective efficacies of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection","volume":"91","author":"Zhang","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.02.016_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.06.004","article-title":"Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice","volume":"132","author":"Zhou","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.02.016_bib33","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.3390\/v7122947","article-title":"Epidemiological research on hand, foot, and mouth disease in mainland China","volume":"7","author":"Zhuang","year":"2015","journal-title":"Viruses"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217307131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217307131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T21:27:55Z","timestamp":1589837275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217307131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":33,"alternative-id":["S0166354217307131"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}